Drug Metabolism and Disposition: 23 (9)

September 01, 1995; Volume 23,Issue 9

You have access
Relevance of tissue distribution studies and cytopharmacology: utility of radioassay combined with autoradiography.
W E Stumpf

Drug Metabolism and Disposition September 1995, 23 (9) 885-886;
You have access
Metabolism of oral 9-cis-retinoic acid in the human. Identification of 9-cis-retinoyl-beta-glucuronide and 9-cis-4-oxo-retinoyl-beta-glucuronide as urinary metabolites.
J O Sass, E Masgrau, J H Saurat and H Nau

Drug Metabolism and Disposition September 1995, 23 (9) 887-891;
You have access
Reactivity of gemfibrozil 1-o-beta-acyl glucuronide. Pharmacokinetics of covalently bound gemfibrozil-protein adducts in rats.
B C Sallustio and D J Foster

Drug Metabolism and Disposition September 1995, 23 (9) 892-899;
You have access
Stereoselective reversible binding properties of the glucuronide conjugates of fenoprofen enantiomers to human serum albumin.
A Bischer, M Iwaki, P Zia-Amirhosseini and L Z Benet

Drug Metabolism and Disposition September 1995, 23 (9) 900-903;
You have access
A comparison of mass balance, pharmacokinetics and disposition of [14C(U)]- and [125I]recombinant human interleukin-2 in cynomolgus monkeys.
R W Nadeau, H Satoh, S Scheide, R Crowl, R Conroy, W A Garland and D J Liberato

Drug Metabolism and Disposition September 1995, 23 (9) 904-909;
You have access
Characterization of an O-glucuronide metabolite of the CCK-B antagonist LY288513 and its plasma levels in mouse, rat, and dog.
J M Woodland and W J Ehlhardt

Drug Metabolism and Disposition September 1995, 23 (9) 910-915;
You have access
Disposition of the opioid antagonist, LY255582, in rats and dogs.
S P Swanson, J Catlow, R C Pohland, S H Chay and T Johnson

Drug Metabolism and Disposition September 1995, 23 (9) 916-921;
You have access
Induction of rodent hepatic drug-metabolizing enzyme activities by the novel anticonvulsant remacemide hydrochloride.
R J Riley, C Lambert, A E Cooper, H Richmond, M Hall, M C Jordan, C J Logan and B Clark

Drug Metabolism and Disposition September 1995, 23 (9) 922-928;
You have access
Determination of human hepatic cytochrome P4501A2 activity in vitro use of tacrine as an isoenzyme-specific probe.
V Spaldin, S Madden, D A Adams, R J Edwards, D S Davies and B K Park

Drug Metabolism and Disposition September 1995, 23 (9) 929-934;
You have access
Comparison of purified human and rabbit serum paraoxonases.
C L Kuo and B N La Du

Drug Metabolism and Disposition September 1995, 23 (9) 935-944;
You have access
Bacterial expression and kinetic characterization of the human monoamine-sulfating form of phenol sulfotransferase.
T C Ganguly, V Krasnykh and C N Falany

Drug Metabolism and Disposition September 1995, 23 (9) 945-950;
You have access
Application of hyphenated LC/NMR and LC/MS techniques in rapid identification of in vitro and in vivo metabolites of iloperidone.
A E Mutlib, J T Strupczewski and S M Chesson

Drug Metabolism and Disposition September 1995, 23 (9) 951-964;
You have access
Mechanisms of tumor modulation by indole-3-carbinol. Disposition and excretion in male Fischer 344 rats.
D M Stresser, D E Williams, D A Griffin and G S Bailey

Drug Metabolism and Disposition September 1995, 23 (9) 965-975;
You have access
Investigation of the metabolism of ebrotidine in human urine by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry.
E Rozman, M T Galceran, L Anglada and C Albet

Drug Metabolism and Disposition September 1995, 23 (9) 976-981;
You have access
Metabolism of [14C]1,3-dinitrobenzene by rat small intestinal mucosa in vitro.
P C Adams and D E Rickert

Drug Metabolism and Disposition September 1995, 23 (9) 982-987;
You have access
Urinary excretion of cicletanine in the rat. Stereochemical aspects.
R Vistelle, D Lamiable, E Morin, T Trenque and M Kaltenbach

Drug Metabolism and Disposition September 1995, 23 (9) 988-992;
You have access
Acidic metabolites of tamoxifen. Aspects of formation and fate in the female rat.
P C Ruenitz and X Bai

Drug Metabolism and Disposition September 1995, 23 (9) 993-998;
You have access
Inhibition and induction of cytochrome P450 isozymes after repetitive administration of imipramine in rats.
Y Masubuchi, C Takahashii, N Fujio, T Horie, T Suzuki, S Imaoka, Y Funae and S Narimatsu

Drug Metabolism and Disposition September 1995, 23 (9) 999-1003;
You have access
Utility of trace trifluoroacetic acid to enhance the quality of proton NMR spectra of xenobiotic metabolites.
G Y Kuo and D M Dulik

Drug Metabolism and Disposition September 1995, 23 (9) 1004-1006;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals